Vance Wealth, Inc. Ark Genomic Revolution ETF (De Transaction History
Vance Wealth, Inc.
- $312 Million
- Q3 2025
A detailed history of Vance Wealth, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Vance Wealth, Inc. holds 10,670 shares of ARKG stock, worth $286,916. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,670
Previous 10,309
3.5%
Holding current value
$286,916
Previous $251,000
17.93%
% of portfolio
0.09%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio